View All Documents & Correspondence
A Composition Comprising Turmeric, And Lecithin And Uses Thereof
Abstract: The present disclosure relates to a composition comprising turmeric, and lecithin for wound healing benefit. The disclosure also provides for a method of using the composition and its formulation for various skin care applications.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. MIRIYALA, Amarnath
2. NARAYANAPERUMAL, Jeyaparthasarathy
3. GOPAL, Ganesh
Specification
Claims:1. A composition comprising:
a) turmeric; and
b) lecithin,
wherein turmeric to lecithin w/w ratio in said composition is in the range of 1:2-1:40.
2. The composition as claimed in claim 1, wherein turmeric to lecithin w/w ratio in said composition is in the range of 1:3-1:30.
3. The composition as claimed in any of the claims 1-2, wherein turmeric to lecithin w/w ratio in said composition is 1:30.
4. A method of preparing a composition as claimed in any of the claims 1-3.
5. A topical formulation comprising:
a) turmeric;
b) lecithin; and
c) at least one carrier, diluent, and excipient,
wherein turmeric to lecithin w/w ratio in said formulation is in the range of 1:2-1:40.
6. The formulation as claimed in claim 5, wherein turmeric to lecithin w/w ratio in said formulation is in the range of 1:3-1:30.
7. The formulation as claimed in any of the claims 5-6, wherein turmeric to lecithin w/w ratio in said formulation is 1:30.
8. A method of preparing a formulation as claimed in any of the claims 5-7.
9. A method for promoting epithelial wound healing, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-3; or a formulation as claimed in any of the claims 5-7: and
b. contacting said composition or formulation with site of epithelial wound,
wherein said method promotes wound healing.
10. A method for promoting muscle healing, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-3; or a formulation as claimed in any of the claims 5-7: and
b. contacting said composition or formulation with muscle,
wherein said method promotes muscle healing.
11. The composition as claimed in claim 1, wherein turmeric weight concentration is in the range of 5-15µg/ml of said composition and lecithin weight concentration in the range of 50-150µg/ml of said composition.
12. A healing patch comprising: (a) a non-adhesive area configured to be placed over the site of wound or over muscle; and (b) an adhesive area configured within the non-adhesive area, wherein the non-adhesive area comprises of a composition as claimed in any of the claims 1-3 or a formulation as claimed in any of the claims 5-7.
, Description:As Attached
Documents
Orders
| Section | Controller | Decision Date |
|---|---|---|
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 6481-CHE-2015-Written submissions and relevant documents [19-03-2024(online)].pdf | 2024-03-19 |
| 1 | Form 5 [02-12-2015(online)].pdf | 2015-12-02 |
| 2 | 6481-CHE-2015-Correspondence to notify the Controller [01-03-2024(online)].pdf | 2024-03-01 |
| 2 | Form 3 [02-12-2015(online)].pdf | 2015-12-02 |
| 3 | Drawing [02-12-2015(online)].pdf | 2015-12-02 |
| 3 | 6481-CHE-2015-US(14)-ExtendedHearingNotice-(HearingDate-05-03-2024).pdf | 2024-02-12 |
| 4 | Description(Complete) [02-12-2015(online)].pdf | 2015-12-02 |
| 4 | 6481-CHE-2015-Written submissions and relevant documents [25-01-2024(online)].pdf | 2024-01-25 |
| 5 | 6481-CHE-2015-Power of Attorney-050116.pdf | 2016-06-17 |
| 5 | 6481-CHE-2015-FORM-26 [11-01-2024(online)].pdf | 2024-01-11 |
| 6 | 6481-CHE-2015-Form 1-050116.pdf | 2016-06-17 |
| 6 | 6481-CHE-2015-Correspondence to notify the Controller [09-01-2024(online)].pdf | 2024-01-09 |
| 7 | 6481-CHE-2015-US(14)-HearingNotice-(HearingDate-12-01-2024).pdf | 2023-12-12 |
| 7 | 6481-CHE-2015-Correspondence-F1-PA-050116.pdf | 2016-06-17 |
| 8 | 6481-CHE-2015-FORM 18 [03-11-2019(online)].pdf | 2019-11-03 |
| 8 | 6481-CHE-2015-FER.pdf | 2021-10-17 |
| 9 | 6481-CHE-2015-CLAIMS [17-05-2021(online)].pdf | 2021-05-17 |
| 9 | 6481-CHE-2015-FORM 4(ii) [15-02-2021(online)].pdf | 2021-02-15 |
| 10 | 6481-CHE-2015-FER_SER_REPLY [17-05-2021(online)].pdf | 2021-05-17 |
| 11 | 6481-CHE-2015-CLAIMS [17-05-2021(online)].pdf | 2021-05-17 |
| 11 | 6481-CHE-2015-FORM 4(ii) [15-02-2021(online)].pdf | 2021-02-15 |
| 12 | 6481-CHE-2015-FER.pdf | 2021-10-17 |
| 12 | 6481-CHE-2015-FORM 18 [03-11-2019(online)].pdf | 2019-11-03 |
| 13 | 6481-CHE-2015-Correspondence-F1-PA-050116.pdf | 2016-06-17 |
| 13 | 6481-CHE-2015-US(14)-HearingNotice-(HearingDate-12-01-2024).pdf | 2023-12-12 |
| 14 | 6481-CHE-2015-Correspondence to notify the Controller [09-01-2024(online)].pdf | 2024-01-09 |
| 14 | 6481-CHE-2015-Form 1-050116.pdf | 2016-06-17 |
| 15 | 6481-CHE-2015-FORM-26 [11-01-2024(online)].pdf | 2024-01-11 |
| 15 | 6481-CHE-2015-Power of Attorney-050116.pdf | 2016-06-17 |
| 16 | 6481-CHE-2015-Written submissions and relevant documents [25-01-2024(online)].pdf | 2024-01-25 |
| 16 | Description(Complete) [02-12-2015(online)].pdf | 2015-12-02 |
| 17 | 6481-CHE-2015-US(14)-ExtendedHearingNotice-(HearingDate-05-03-2024).pdf | 2024-02-12 |
| 17 | Drawing [02-12-2015(online)].pdf | 2015-12-02 |
| 18 | 6481-CHE-2015-Correspondence to notify the Controller [01-03-2024(online)].pdf | 2024-03-01 |
| 18 | Form 3 [02-12-2015(online)].pdf | 2015-12-02 |
| 19 | Form 5 [02-12-2015(online)].pdf | 2015-12-02 |
| 19 | 6481-CHE-2015-Written submissions and relevant documents [19-03-2024(online)].pdf | 2024-03-19 |
Search Strategy
| 1 | 2020-07-2815-10-09E_29-07-2020.pdf |
| 1 | tkdlE_14-08-2020.pdf |
| 2 | 2020-07-2815-10-09E_29-07-2020.pdf |
| 2 | tkdlE_14-08-2020.pdf |